Boston Scientific’s share price — which medical device competitors have long envied — sputtered Feb. 4 after the company ...

Boston Scientific stock fell 8.4% despite beating Q4 earnings as weak Q1 guidance and electrophysiology division miss ...

I'll be keeping a close eye on Boston Scientific stock following the market's peculiar reaction to its solid earnings report.

Boston Scientific Corporation (NYSE: BSX) reported Q4 2025 revenues of $5.29B, beating management guidance and consensus estimate.

Medical device company Boston Scientific (NYSE:BSX) in Q4 CY2025, with sales up 15.9% year on year to $5.29 billion. The ...

Q4 2025 earnings call recap: revenue, EPS beat, 2026 organic growth & guidance, key drivers (EP, WATCHMAN) and risks—read now.

View Boston Scientific Corporation BSX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Boston Scientific’s last mega-deal didn’t go so well. The medtech company with a large Minnesota presence acquired Arden Hills’ Guidant for $27 billion in 2006. This triggered years of legal ...